Quantum Apitherapy Industry Forum | Regenerative Bioactive Innovation & Quantum Biology
Quantum Apitherapy Industry Conversation
The future of Mānuka honey may not be in the jar.
The Future of Bioactive Regenerative Platforms
Beyond UMF and MGO there is an industry opportunity where Quantum Biology Meets Apitherapy. Regenerative Signalling & Coherent Bioactivity. Industry Collaboration & Licensing Opportunities. Join the Quantum Apitherapy Network.

Join a private Zoom session on Quantum Apitherapy and discover a new commercial lens on Mānuka bioactivity, protein–phenolic systems, and category expansion beyond commodity honey.
Reserve your place
The details of the zoom link will be sent to you once you have reserved your spot. If you would like a recording but cannot attend then please signup.
A category shift is emerging.
Beyond Traditional Honey Science
Quantum Apitherapy explores the convergence of bioactive Manuka systems, regenerative signalling biology, proton dynamics, aromatic electron systems, and next-generation wellness innovation.
This industry conversation brings together researchers, formulators, investors, clinicians, biotech leaders, and advanced wellness innovators exploring the future of coherent bioactive technologies.
Explore Topics Including:
- Redox signalling biology
- Structured phenolic/protein interactions
- Mitochondrial support systems
- Regenerative care innovation
- Cognitive resilience technologies
- Bioactive formulation science
- Quantum biology concepts in healthcare
- Advanced apitherapy applications
- Clinical and biotech commercialization pathways

For years, the Manuka honey industry has centred value around UMF and MGO. This session explores a broader bioactivity framework that could open new positioning in regenerative care, biotech licensing, and clinical innovation sectors with the development of Quantum Apitherapy.
What you’ll learn
- Increase the value of your Manuka honey by gaining control over MGO generation.
- Learn how quantum apitherapy works.
- Learn how Manuka honey stores time energy for healing and regeneration.
- Learn what role light plays in the Manuka honey story.
Designed to create urgency, clarity, and opportunity.
This is not a general webinar. It is a targeted briefing for people who want to understand where the next defensible value in Mānuka honey could come from.

1.0 Industry repositioning
See how quantum apitherapy can move the conversation from commodity product claims toward higher-value biological systems.
2.0 New science narrative
Explore a broader framework around protein–phenolic interactions, light-driven chemistry, and bioactivity beyond simple grading metrics.
3.0 Commercial leverage
Understand how this could support licensing pathways, premium product architecture, and stronger category ownership.
4.0 First-mover advantage
Be early to a conversation that could influence how Mānuka honey is framed, protected, and monetized over the next decade.
Who should attend
Built for decision-makers, not spectators.
If you shape strategy, commercialization, product development, or industry direction, this session is for you.
Reserve your place
Private Zoom session on Quantum Apitherapy and the next phase of Mānuka honey value creation.
By registering, you are expressing interest in attending a private industry Zoom session.
Who am I
Proven track record in regenerative medicine with the development of the STOF patented wound healing technology made from sheep stomach for Aroa Biosurgery.
https://patents.justia.com/patent/20150337019
The present disclose relates to anti-inflammatory proteins/peptides, their uses, methods of preparation and methods of their detection. In particular, the invention relates to major royal jelly proteins modified by methylglyoxal and fragments thereof from a Leptospermum derived honey and royal jelly.
16 years researching Manuka honeys quantum properties. Discovery of polymeric glyoxal in pollen as the light based pollen tube formation system. Pollen being fundamental in the generation of MGO.
New Science
Identified the process linked to hydrogen tunnelling in Manuka honey and the formation of time energy for healing and regeneration.
Discovery of the photo-Fenton (light stimulation) production of superoxide and hydroxyl radicals in Manuka honey.
Discovery of HDAC inhibition of CEL adducts in MGO modified royal jelly proteins with biotherapeutic anti-inflammatory and anti-cancer potential.
Quantum coherence generation processes linked to quantum entanglement operating in the Manuka honey which is the basis of having the ability to prevent disease formation.
Patent: US20240293472A1
Co-Founder · Quantum Biology, He-BEC Theory & Commercial Translation
Wellington, New Zealand
Dr Keryn Johnson is a scientist and entrepreneur working at the intersection of quantum biology, regenerative medicine, and cosmology.
His research includes the development of:
- The He-BEC Isotropic Singularity model
- SUSY inversion frameworks
- Revised quark charge models
- The aromatic ring as a biological timing system
He is also the founder of Quantum Technologies Ltd and the OH BEE HAVE empowering healing(TM) platform, translating advanced scientific frameworks into real-world products and commercial systems.
Dr Johnson provides the biological and theoretical bridge, connecting physics-based systems to living systems and scalable applications.
Key Highlights
- PhD in Biochemistry
- MS in Molecular Genetics
- BSc (double Major) in Plant and Microbial Sciences and Biochemistry
- Founder of Quantum Technologies Ltd
- Founder of Quantum Biology Research Institute
- Pioneer in quantum biology and biological signal systems
- Deep-tech entrepreneur translating science into products
Focus Keywords
- Quantum Apitherapy
- Quantum Apitherapy industry
- regenerative bioactive platform
- Manuka honey biotechnology
- quantum biology innovation
- aromatic proton biology
- regenerative signalling biology
- bioactive honey technology
- redox signalling platform
- coherent hydration biology
- mitochondrial support innovation
- regenerative wellness technology
- honey biotech licensing
- cognitive resilience biotechnology
- advanced apitherapy